Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $250.00 price target on Palvella Therapeutics (NASDAQ: PVLA)The analyst commented, "Yesterday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments